Preferred Label : Eptifibatide;

MeSH definition : Cyclic peptide that acts as a platelet glycoprotein IIB-IIIA antagonist, reversibly inhibiting the binding of FIBRINOGEN; VON WILLEBRAND FACTOR; and other adhesive molecules to the GPIIB-IIA RECEPTORS of platelets. It is used in the management of UNSTABLE ANGINA and in patients undergoing coronary ANGIOPLASTY and stenting procedures.; Cyclic peptide that acts as a platelet glycoprotein IIB-IIIA antagonist, reversibly inhibiting the binding of FIBRINOGEN; VON WILLEBRAND FACTOR; and other adhesive molecules to the GPIIB-IIIA RECEPTORS of platelets. It is used in the management of UNSTABLE ANGINA and in patients undergoing coronary ANGIOPLASTY and stenting procedures.;

MeSH synonym : Epifibratide; Epifibatide; 7H-Pyrrolo(2,1-g)(1,2,5,8,11,14,17,20)dithiahexaazacyclotricosine-17-acetic acid, 3-(aminocarbonyl)-11-(4-((aminoiminomethyl)amino)butyl)docosahydro-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxo-, (3R,11S,17S,20S,25aS)-;

MeSH hyponym : Integrelin;

MeSH CAS label : 7H-Pyrrolo(2,1-g)(1,2,5,8,11,14,17,20)dithiahexaazacyclotricosine-17-acetic acid, 3-(aminocarbonyl)-11-(4-((aminoiminomethyl)amino)butyl)docosahydro-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxo-, (3R,11S,17S,20S,25aS)-;

Wikipedia link : https://en.wikipedia.org/wiki/Eptifibatide;

UNII : NA8320J834;

Details


Main resources

You can consult :

Cyclic peptide that acts as a platelet glycoprotein IIB-IIIA antagonist, reversibly inhibiting the binding of FIBRINOGEN; VON WILLEBRAND FACTOR; and other adhesive molecules to the GPIIB-IIA RECEPTORS of platelets. It is used in the management of UNSTABLE ANGINA and in patients undergoing coronary ANGIOPLASTY and stenting procedures.
Cyclic peptide that acts as a platelet glycoprotein IIB-IIIA antagonist, reversibly inhibiting the binding of FIBRINOGEN; VON WILLEBRAND FACTOR; and other adhesive molecules to the GPIIB-IIIA RECEPTORS of platelets. It is used in the management of UNSTABLE ANGINA and in patients undergoing coronary ANGIOPLASTY and stenting procedures.

https://ansm.sante.fr/informations-de-securite/arret-de-commercialisation-dintegrilin-recommandations-de-lansm
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/integrilin-0-75-mg-ml-et-2-mg-ml-solution-injectable-eptifibatide
2023
false
false
false
France
French
drug information
guideline
Eptifibatide

---
Eptifibatide Accord - eptifibatide
https://www.ema.europa.eu/medicines/human/EPAR/eptifibatide-accord
2016
false
United Kingdom
French
English
syndication feed
drugs, generic
drug interactions
pregnancy
breast feeding
drug therapy, combination
infusions, intravenous
injections, intravenous
recurrence
Eptifibatide 2mg/mL injection solution 10mL vial (product)
Eptifibatide 750micrograms/mL infusion solution 100mL vial (product)
Product containing eptifibatide (medicinal product)
peptides
adult
myocardial infarction
angina, unstable
platelet aggregation inhibitors
treatment outcome
drug evaluation, preclinical
eptifibatide
peptides
drug evaluation
package leaflet
summary of product characteristics
Eptifibatide
Eptifibatide

---
http://www.has-sante.fr/portail/jcms/c_2613509/fr/eptifibatide-accord
2016
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
Eptifibatide 750micrograms/mL infusion solution 100mL vial (product)
Eptifibatide 2mg/mL injection solution 10mL vial (product)
eptifibatide
peptides
Eptifibatide

---
https://www.ema.europa.eu/medicines/human/EPAR/Integrilin
2012
false
United Kingdom
French
English
syndication feed
peptides
adult
myocardial infarction
angina, unstable
platelet aggregation inhibitors
treatment outcome
drug evaluation
eptifibatide
peptides
drug evaluation
package leaflet
summary of product characteristics
Eptifibatide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60124020
2008
France
French
peptides
infusions, intravenous
pharmaceutical solutions
eptifibatide
drug information
Eptifibatide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66506404
2008
France
French
peptides
infusions, intravenous
pharmaceutical solutions
eptifibatide
drug information
Eptifibatide

---
Nous contacter.
09/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.